Cargando…

Mefloquine for preventing malaria in pregnant women

Mostrar otras versiones (1)

BACKGROUND: The World Health Organization recommends intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine‐pyrimethamine for malaria for all women who live in moderate to high malaria transmission areas in Africa. However, parasite resistance to sulfadoxine‐pyrimethamine has been in...

Descripción completa

Detalles Bibliográficos
Autores principales:	González, Raquel, Pons‐Duran, Clara, Piqueras, Mireia, Aponte, John J, ter Kuile, Feiko O, Menéndez, Clara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2018
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517148/ https://www.ncbi.nlm.nih.gov/pubmed/30480761 http://dx.doi.org/10.1002/14651858.CD011444.pub3

Ejemplares similares

Mefloquine for preventing malaria in pregnant women
por: González, Raquel, et al.
Publicado: (2018)

Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya
por: Green, Michael, et al.
Publicado: (2016)

Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients
por: Lee, Sue J., et al.
Publicado: (2017)

Gilding the Lily? Enhancing Antenatal Malaria Prevention in HIV-Infected Women
por: ter Kuile, Feiko O., et al.
Publicado: (2017)

Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment
por: Radeva‐Petrova, Denitsa, et al.
Publicado: (2014)

Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Negative Women: A Multicentre Randomized Controlled Trial
por: González, Raquel, et al.
Publicado: (2014)

Dihydroartemisinin–piperaquine holds promise as an option for malaria prevention in pregnancy
por: Hill, Jenny, et al.
Publicado: (2016)

Intermittent Preventive Treatment of Malaria in Pregnancy with Mefloquine in HIV-Infected Women Receiving Cotrimoxazole Prophylaxis: A Multicenter Randomized Placebo-Controlled Trial
por: González, Raquel, et al.
Publicado: (2014)

Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy
por: Haaland, Richard E., et al.
Publicado: (2018)

Mefloquine safety and tolerability in pregnancy: a systematic literature review
por: González, Raquel, et al.
Publicado: (2014)

Prevalence of malaria infection in pregnant women compared with children for tracking malaria transmission in sub-Saharan Africa: a systematic review and meta-analysis
por: van Eijk, Anna M, et al.
Publicado: (2015)

Clinical malaria in African pregnant women
por: Bardají, Azucena, et al.
Publicado: (2008)

Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort Study
por: Rupérez, María, et al.
Publicado: (2016)

Evaluation of the safety and efficacy of dihydroartemisinin–piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: protocol of a multicentre, two-arm, randomised, placebo-controlled, superiority clinical trial (MAMAH project)
por: González, Raquel, et al.
Publicado: (2021)

Access and Use of Interventions to Prevent and Treat Malaria among Pregnant Women in Kenya and Mali: A Qualitative Study
por: Hill, Jenny, et al.
Publicado: (2015)

Effect of dihydroartemisinin/piperaquine for malaria intermittent preventive treatment on dolutegravir exposure in pregnant women living with HIV
por: Banda, Clifford G., et al.
Publicado: (2022)

Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data
por: van Eijk, Anna Maria, et al.
Publicado: (2011)

Insecticide-Treated Nets for the Prevention of Malaria in Pregnancy: A Systematic Review of Randomised Controlled Trials
por: Gamble, Carol, et al.
Publicado: (2007)

Drugs for Intermittent Preventive Treatment of Malaria in Pregnancy: Current Knowledge and Way Forward
por: Figueroa-Romero, Antia, et al.
Publicado: (2022)

Community delivery of malaria intermittent preventive treatment in pregnancy: protocol of a quasi-experimental evaluation through multistage cluster sampling household surveys in four sub-Saharan African countries
por: Pons-Duran, Clara, et al.
Publicado: (2021)

Mefloquine for preventing malaria during travel to endemic areas
por: Tickell‐Painter, Maya, et al.
Publicado: (2017)

Intermittent screening and treatment with dihydroartemisinin-piperaquine and intermittent preventive therapy with sulfadoxine-pyrimethamine have similar effects on malaria antibody in pregnant Malawian women
por: Teo, Andrew, et al.
Publicado: (2019)

Perceptions of Malaria in Pregnancy and Acceptability of Preventive Interventions among Mozambican Pregnant Women: Implications for Effectiveness of Malaria Control in Pregnancy
por: Boene, Helena, et al.
Publicado: (2014)

Adolescent, Pregnant, and HIV-Infected: Risk of Adverse Pregnancy and Perinatal Outcomes in Young Women from Southern Mozambique
por: Pons-Duran, Clara, et al.
Publicado: (2021)

Intermittent screening and treatment or intermittent preventive treatment compared to current policy of single screening and treatment for the prevention of malaria in pregnancy in Eastern Indonesia: acceptability among health providers and pregnant women
por: Hoyt, Jenna, et al.
Publicado: (2018)

Pregnancy Exposure Registries for Assessing Antimalarial Drug Safety in Pregnancy in Malaria-Endemic Countries
por: Dellicour, Stephanie, et al.
Publicado: (2008)

Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin-piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis
por: Gutman, Julie, et al.
Publicado: (2017)

The Performance of a Rapid Diagnostic Test in Detecting Malaria Infection in Pregnant Women and the Impact of Missed Infections
por: Williams, John E., et al.
Publicado: (2016)

Estimated impact on birth weight of scaling up intermittent preventive treatment of malaria in pregnancy given sulphadoxine-pyrimethamine resistance in Africa: A mathematical model
por: Walker, Patrick G. T., et al.
Publicado: (2017)

Impact of Dolutegravir-Based Antiretroviral Therapy on Piperaquine Exposure following Dihydroartemisinin-Piperaquine Intermittent Preventive Treatment of Malaria in Pregnant Women Living with HIV
por: Banda, Clifford G., et al.
Publicado: (2022)

Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria
por: Gutman, Julie, et al.
Publicado: (2009)

Prioritizing Pregnant Women for Long-Lasting Insecticide Treated Nets through Antenatal Care Clinics
por: Hill, Jenny, et al.
Publicado: (2014)

Non-falciparum malaria infections in pregnant women in West Africa
por: Williams, John, et al.
Publicado: (2016)

Mefloquine as a prophylaxis for malaria needs to be revisited
por: Ahmad, Sundus Shafat, et al.
Publicado: (2021)

SARS-CoV-2 Seropositivity and HIV Viral Load Among Mozambican Pregnant Women
por: González, Raquel, et al.
Publicado: (2023)

Prediction of improved antimalarial chemotherapy of artesunate-mefloquine in combination with mefloquine sensitive and resistant Plasmodium falciparum malaria
por: Saeheng, Teerachat, et al.
Publicado: (2023)

Women's Access and Provider Practices for the Case Management of Malaria during Pregnancy: A Systematic Review and Meta-Analysis
por: Hill, Jenny, et al.
Publicado: (2014)

Global estimates of the number of pregnancies at risk of malaria from 2007 to 2020: a demographic study
por: Reddy, Valentina, et al.
Publicado: (2022)

The Malaria in Pregnancy Library: a bibliometric review
por: van Eijk, Anna M, et al.
Publicado: (2012)

Malaria Prevention with IPTp during Pregnancy Reduces Neonatal Mortality
por: Menéndez, Clara, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ijgp0bb1clj3k525diogb5le19